GFI1 and lung neuroendocrine neoplasm: Gfi-1 co-expression with neuroendocrine markers, including the DCV-related protein chromogranin A and calcitonin peptide, in small cell lung carcinoma (SCLC) strongly suggests its involvement in the maintenance of the neoplastic phenotype of neuroendocrine lung tumors [60].